Ramazan Omer Yazar

Ramazan Omer Yazar

Auto-generated profile, based on publicly available information

Ramazan Omer Yazar

Univ Hlth Sci Turkey, Istanbul Bagcilar Training & Res Hosp, Clin Urol, Istanbul, Turkiye

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2022 in Renal Failure
Verified
Journal Article
Open access
MTMustafa Zafer Temiz
Mustafa Zafer Temiz
IHIbrahim HACIBEY
Ibrahim HACIBEY
RYRamazan Omer Yazar
Ramazan Omer Yazar
MSMehmet Salih Sevdi
Mehmet Salih Sevdi
SKSuat Hayri Kucuk
Suat Hayri Kucuk
AMAhmet Yaser Muslumanoglu
Ahmet Yaser Muslumanoglu
Literature with regard to coronavirus disease 2019 (COVID-19) associated morbidities and the risk factors for death are still emerging. In this study, we investigated the presence of kidney damage ...

1 March 2023 in Medical Bulletin of Haseki
Verified
Journal Article
Closed access
ACAykut Colakerol
Aykut Colakerol
MTMustafa Zafer Temiz
Mustafa Zafer Temiz
YFYigit Can Filtekin
Yigit Can Filtekin
SSSergen Sahin
Sergen Sahin
RYRamazan Omer Yazar
Ramazan Omer Yazar
AMAhmet Yaser Muslumanoglu
Ahmet Yaser Muslumanoglu

1 January 2023 in Journal of Surgery and Medicine
Verified
Journal Article
Open access
PDF file
ACAykut Colakerol
Aykut Colakerol
MTMustafa Zafer Temiz
Mustafa Zafer Temiz
YFYigit Can Filtekin
Yigit Can Filtekin
SSSergen Sahin
Sergen Sahin
RYRamazan Omer Yazar
Ramazan Omer Yazar
AMAhmet Yaser Muslumanoglu
Ahmet Yaser Muslumanoglu
Background/Aim: Several blood and serum-based parameters have been described as prognostic markers of clear cell renal cell carcinoma (ccRCC). But most of these markers have inconsistent results and are not used in routine clinical practice. Therefore, novel potential predictor biomarkers are needed for the management of ccRCC patients in clinical practice. Here, we investigate the predictive value of a novel marker, serum C-NLR score, for pathological characteristics and oncological outcomes of ccRCC. Methods: A total of 162 RCC patients who underwent radical or partial nephrectomy between January 2015 and January 2021 were evaluated in a retrospective cohort study setting. The serum C-NLR score was compared according to the tumor histopathology-associated parameters. The predictive role of those parameters and C-NLR score on the oncological outcomes of ccRCC was also investigated. Results: The median serum C-NLR scores exhibited statistically significant increases in ccRCC patients with pathological necrosis, lymphovascular invasion, and variant differentiation. Among histopathological characteristics, only tumor necrosis and variant differentiation were associated with overall survival (OS) and tumor grade with metastasis-free survival (MFS) (no metastasis detected in grade 1–2 tumors) in Kaplan Meier analyses. Serum C-NLR score was also associated with OS but not MFS. In the univariate analyses, tumor necrosis, variant differentiation, and C-NLR score were associated with OS of localized RCC patients who underwent nephrectomy (HR: 0.29; 95% CI: 0.08–1.01; P=0.04, HR: 6.01; 95% CI: 1.66–21.82; P=0.006 and, HR: 1.21; 95% CI: 0.20–5.16; P=0.04). However, in the multivariate analysis, only variant differentiation and C-NLR score were associated with OS (HR: 1.43; 95% CI: 0.82–2.98; P=0.03 and HR: 1.21; 95% CI: 0.20–5.16; P=0.04). Tumor grade was directly associated with MFS because grade 1–2 tumors did not exhibit any metastasis. Conclusion: Serum C-NLR score was higher in worse histopathological entities. Moreover, it predicts the OS for patients with ccRCC as an independent factor.